Nature Reviews Clinical Oncology

Vol. 22, Issue 3 Issue 3 2025
12
Articles

Articles in this Issue

Intermediate-affinity CD19-directed CAR T cell product obecabtagene autoleucel demonstrates favourable safety and efficacy in R/R B-ALL

Rawan G. Faramand, Frederick L. Locke Mar 01, 2025 pp. 161-162 10.1038/s41571-025-00993-4

Thermal ablation is safer than resection of colorectal liver lesions

Diana Romero Mar 01, 2025 pp. 158-158 10.1038/s41571-025-00994-3

Early promising results with addition of an ICI and an anti-angiogenic to TACE

Diana Romero Mar 01, 2025 pp. 157-157 10.1038/s41571-025-00990-7

Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncology

Branko Cuglievan, Vivek Subbiah Mar 01, 2025 pp. 155-156 10.1038/s41571-025-00989-0

Early intervention with daratumumab improves survival for patients with high-risk smouldering myeloma

Omar Nadeem, Irene M. Ghobrial Mar 01, 2025 pp. 159-160 10.1038/s41571-025-00987-2

Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?

Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio et al. Mar 01, 2025 pp. 215-231 10.1038/s41571-024-00985-w

Adding brentuximab vedotin to lenalidomide and rituximab improves OS in R/R DLBCL

David Killock Mar 01, 2025 pp. 158-158 10.1038/s41571-025-00988-1

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach

Miguel Lopez de Rodas, Maria Villalba-Esparza, Miguel F. Sanmamed et al. Mar 01, 2025 pp. 163-181 10.1038/s41571-024-00984-x

Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions

Yibei Wang, Mohammed Safi, Fred R. Hirsch et al. Mar 01, 2025 pp. 200-214 10.1038/s41571-024-00979-8

Women with clinically node negative breast cancer can safely avoid axillary surgery

Peter Sidaway Mar 01, 2025 pp. 158-158 10.1038/s41571-024-00982-z

Treatment advances across the cervical cancer spectrum

Alex A. Francoeur, Bradley J. Monk, Krishnansu S. Tewari Mar 01, 2025 pp. 182-199 10.1038/s41571-024-00977-w

Imlunestrant shows efficacy both with and without abemaciclib

David Killock Mar 01, 2025 pp. 157-157 10.1038/s41571-024-00983-y

All Issues

Issue 7 - Issue 7 11 Issue 6 - Issue 6 10 Issue 5 - Issue 5 10 Issue 4 - Issue 4 10 Issue 3 - Issue 3 10 Issue 2 - Issue 2 9 Issue 1 - Issue 1 12
Issue 9 - Issue 9 11 Issue 8 - Issue 8 14 Issue 7 - Issue 7 10 Issue 6 - Issue 6 9 Issue 5 - Issue 5 11 Issue 4 - Issue 4 10 Issue 3 - Issue 3 12 Issue 2 - Issue 2 8 Issue 12 - Issue 12 13 Issue 11 - Issue 11 9 Issue 10 - Issue 10 8 Issue 1 - Issue 1 12

Journal Info

Publisher Springer Science and Business Media LLC
ISSN 1759-4774
E-ISSN 1759-4782
Subject Medicine
Language English
View Full Journal Page